Authors: H. Hudečková 1; Š. Straka 2; M. Avdičová 3; Š. Rusňáková 4 Authors‘ workplace: Odbor epidemiológie, Štátny zdravotný ústav, Martin 2 Ústav epidemiológie, Jesseniova lekárska fakulta Univerzity Komenského, Martin 3 Odbor epidemiológie, Štátny zdravotný ústav, Banská Bystrica 4 Neštátne zdravotnícke zariadenie pre deti a dorast, Marti 1 Published in: Epidemiol. Mikrobiol. Imunol. , 2001, č. 1, s. 31-35 Category:
The epidemiological situation as regards measles, rubella and mumps in Slovakia before vaccinationand after its introduction in 1996, is analysed. On the basis of model costs of treatment of thesediseases before vaccination and costs of treatment in 1996 including costs of vaccination, the authorscalculated the total saved costs (549.7 mil. Sk), cost-effectiveness (10 680 Sk), as well as thecost-benefit.
Key words: measles, rubella and mumps vaccination – saved costs – cost-effectiveness – cost-benefit.
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
